HUP0100456A3 - Ifnar2/ifn complex - Google Patents

Ifnar2/ifn complex

Info

Publication number
HUP0100456A3
HUP0100456A3 HU0100456A HUP0100456A HUP0100456A3 HU P0100456 A3 HUP0100456 A3 HU P0100456A3 HU 0100456 A HU0100456 A HU 0100456A HU P0100456 A HUP0100456 A HU P0100456A HU P0100456 A3 HUP0100456 A3 HU P0100456A3
Authority
HU
Hungary
Prior art keywords
ifnar2
ifn complex
ifn
complex
Prior art date
Application number
HU0100456A
Other languages
English (en)
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of HUP0100456A1 publication Critical patent/HUP0100456A1/hu
Publication of HUP0100456A3 publication Critical patent/HUP0100456A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HU0100456A 1997-12-19 1998-12-18 Ifnar2/ifn complex HUP0100456A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6829597P 1997-12-19 1997-12-19
PCT/US1998/026926 WO1999032141A1 (en) 1997-12-19 1998-12-18 Ifnar2/ifn complex

Publications (2)

Publication Number Publication Date
HUP0100456A1 HUP0100456A1 (hu) 2001-06-28
HUP0100456A3 true HUP0100456A3 (en) 2003-09-29

Family

ID=22081665

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0100456A HUP0100456A3 (en) 1997-12-19 1998-12-18 Ifnar2/ifn complex

Country Status (28)

Country Link
US (1) US6372207B1 (hu)
EP (1) EP1037658B1 (hu)
JP (1) JP4601163B2 (hu)
KR (1) KR100593981B1 (hu)
CN (1) CN1241638C (hu)
AR (1) AR020315A1 (hu)
AT (1) ATE218362T1 (hu)
AU (1) AU755078B2 (hu)
BG (1) BG64920B1 (hu)
BR (1) BR9813753A (hu)
CA (1) CA2311648C (hu)
DE (1) DE69805844T2 (hu)
DK (1) DK1037658T3 (hu)
EA (1) EA003635B1 (hu)
EE (1) EE200000355A (hu)
ES (1) ES2174530T3 (hu)
HK (1) HK1032914A1 (hu)
HU (1) HUP0100456A3 (hu)
IL (2) IL136855A0 (hu)
NO (1) NO20002691L (hu)
NZ (1) NZ504771A (hu)
PL (1) PL197568B1 (hu)
PT (1) PT1037658E (hu)
SK (1) SK9222000A3 (hu)
TR (1) TR200001961T2 (hu)
UA (1) UA74132C2 (hu)
WO (1) WO1999032141A1 (hu)
ZA (1) ZA9811634B (hu)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL122818A0 (en) * 1997-07-10 1998-08-16 Yeda Res & Dev Chimeric interleukin-6 soluble receptor/ligand protein analogs thereof and uses thereof
AUPP670698A0 (en) * 1998-10-23 1998-11-19 Monash University A method of regulation
US7138379B2 (en) * 2000-07-26 2006-11-21 Schering Aktiengesellschaft Use of the interferon receptor 2c polypeptide chain to enhance the anti-growth effects of type I interferons
IL147414A0 (en) 2001-12-31 2002-08-14 Yeda Res & Dev Ifnar2 mutants, their production and use
US20040175359A1 (en) * 2002-11-12 2004-09-09 Desjarlais John Rudolph Novel proteins with antiviral, antineoplastic, and/or immunomodulatory activity
PL1666496T3 (pl) * 2003-08-25 2014-08-29 Toray Industries Kompozyt interferonu beta
CN100400664C (zh) * 2005-09-06 2008-07-09 中国人民解放军第四军医大学 肿瘤血管导向肽与人干扰素α-2b的融合蛋白的制备方法
WO2008130382A2 (en) 2006-10-31 2008-10-30 East Carolina University Fusion proteins comprising an anti -inflammatory cytokine and an antigen for treatment of immune disorders
GB0715383D0 (en) * 2007-08-08 2007-09-19 Asterion Ltd Interferon
GB0815216D0 (en) * 2008-08-21 2008-09-24 Asterion Ltd Interleukin
EP3348275A3 (en) 2009-03-31 2018-10-24 East Carolina University Cytokines and neuroantigens for treatment of immune disorders
KR101293363B1 (ko) * 2011-02-28 2013-08-05 성균관대학교산학협력단 인터페론 수용체 유전자를 포함하는 조류독감 예방용 조성물
US9902770B2 (en) * 2013-03-15 2018-02-27 Janssen Biotech, Inc. Interferon alpha and omega antibody antagonists
LT6164B (lt) 2013-10-15 2015-06-25 Uab Biotechnologinės Farmacijos Centras "Biotechpharma" Sulieti interferono-alfa 5 baltymai su kitu citokinu ir jų gamybos būdas
WO2018236701A1 (en) * 2017-06-20 2018-12-27 The Board Of Regents Of The University Of Texas System INTERFERON PRODRUCE FOR THE TREATMENT OF CANCER
WO2019040674A1 (en) 2017-08-22 2019-02-28 Sanabio, Llc SOLUBLE INTERFERON RECEPTORS AND USES THEREOF
CN112646783B (zh) * 2020-12-30 2023-12-01 广州医科大学附属市八医院 表达基因、经基因修饰的受精卵的构建方法和小鼠模型的构建方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL106591A (en) 1992-09-03 2008-03-20 Yeda Res & Dev Interferon alpha/beta binding protein, its preparation and pharmaceutical compositions containing it
US5821078A (en) * 1992-09-03 1998-10-13 Yeda Research And Development Co. Ltd. Nucleic acid encoding interferon-α/β binding protein
IL107378A (en) * 1993-10-24 2005-05-17 Yeda Res & Dev SOLUBLE INTERFERON alpha-RECEPTOR, ITS PREPARATION AND USE

Also Published As

Publication number Publication date
ZA9811634B (en) 1999-06-22
AU755078B2 (en) 2002-12-05
EP1037658A1 (en) 2000-09-27
AU1926999A (en) 1999-07-12
DE69805844D1 (de) 2002-07-11
BG64920B1 (bg) 2006-09-29
NO20002691L (no) 2000-08-18
CA2311648A1 (en) 1999-07-01
DK1037658T3 (da) 2002-09-30
JP4601163B2 (ja) 2010-12-22
EE200000355A (et) 2001-10-15
ES2174530T3 (es) 2002-11-01
UA74132C2 (uk) 2005-11-15
PT1037658E (pt) 2002-10-31
SK9222000A3 (en) 2001-01-18
BR9813753A (pt) 2000-10-10
CA2311648C (en) 2010-11-16
PL341423A1 (en) 2001-04-09
PL197568B1 (pl) 2008-04-30
ATE218362T1 (de) 2002-06-15
CN1241638C (zh) 2006-02-15
EA200000685A1 (ru) 2000-12-25
EA003635B1 (ru) 2003-08-28
DE69805844T2 (de) 2002-10-24
AR020315A1 (es) 2002-05-08
BG104539A (en) 2001-04-30
IL136855A (en) 2007-07-24
US6372207B1 (en) 2002-04-16
WO1999032141A1 (en) 1999-07-01
NZ504771A (en) 2002-09-27
NO20002691D0 (no) 2000-05-25
EP1037658B1 (en) 2002-06-05
JP2001526242A (ja) 2001-12-18
HUP0100456A1 (hu) 2001-06-28
KR20010032836A (ko) 2001-04-25
KR100593981B1 (ko) 2006-06-30
HK1032914A1 (en) 2001-08-10
IL136855A0 (en) 2001-06-14
TR200001961T2 (tr) 2000-11-21
CN1282255A (zh) 2001-01-31

Similar Documents

Publication Publication Date Title
GB2325840B (en) Heater-sensor complex
HK1026616A1 (en) Anti-proliferative preparations
DE69810130D1 (en) Rotationspumpe mit tauchrotor
PL334447A1 (en) Inhaler
PL335799A1 (en) Inhaler
PL335690A1 (en) Inhaler
PL335701A1 (en) Inhaler
PT1090128E (pt) Polipéptidos dependentes da vitamina k modificados
AU135548S (en) Inhaler
AU135120S (en) Inhaler
AU135340S (en) An inhaler
SG76535A1 (en) Pharmaceutical agents
IL136855A0 (en) Ifnar2/ifn complex
PL337723A1 (en) Inhalable tocopherol-stabilised prolyposomic powders
EP1008352A4 (en) Cerebrospinal PROTECTOR
GB9727518D0 (en) Use
ZA987483B (en) Contrast agent
EP1001981A4 (en) HEREGULIN-LIKE FACTOR
ZA98566B (en) Antiviral agents
GB2320900B (en) Inhalers
GB9721053D0 (en) Software guardcard
GB9821760D0 (en) Framelock component
SI1037658T1 (en) Ifnar/ifn complex
GB9700014D0 (en) Interface
MD823F1 (en) Antimutagenous agent

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees